Orhan Ilkay Erdogan
Department of Pharmacognosy, Faculty of Pharmacy, Gazi University, 06330 Ankara, Turkey.
Curr Pharm Des. 2016;22(3):268-76. doi: 10.2174/1381612822666151112150612.
Monoamine oxidase (MAO, E.C. 1.4.3.4) is a flavin-adenine type of enzyme with two isoforms referred to MAO-A and MAO-B that function for oxidation of monoamines. While MAO-A inhibitors are effective as antidepressant and anxiolytic drugs (e.g. chlorgyline, moclobemide, and lazabemide), inhibitors of MAO-B (e.g. Ldeprenyl, pargyline, and rasagiline) are used against neurodegenerative diseases such as Parkinson's and Alzheimer's diseases. Considering the need for novel MAO inhibitors due to side effects of the current ones, natural products have become attractive targets for researchers. Up till now, many studies revealed strong MAO inhibitory activity of flavonoid, xanthone, alkaloid, and coumarin derivatives from herbal sources, which also become good models for the synthetic MAO inhibitors. For this purpose, the present review focuses on examples of in vitro and in vivo MAO-inhibiting natural compounds of plant origin from a wide variety of chemical classes isolated mainly between 2000 - 2015.
单胺氧化酶(MAO,E.C. 1.4.3.4)是一种黄素腺嘌呤类酶,有MAO-A和MAO-B两种同工型,作用是氧化单胺。虽然MAO-A抑制剂作为抗抑郁药和抗焦虑药有效(如氯吉兰、吗氯贝胺和拉扎贝胺),但MAO-B抑制剂(如司来吉兰、帕吉林和雷沙吉兰)用于治疗帕金森病和阿尔茨海默病等神经退行性疾病。鉴于现有MAO抑制剂存在副作用,需要新型MAO抑制剂,天然产物已成为研究人员感兴趣的目标。到目前为止,许多研究表明,来自草药的黄酮类、呫吨酮类、生物碱类和香豆素类衍生物具有很强的MAO抑制活性,这些衍生物也成为合成MAO抑制剂的良好模型。为此,本综述重点介绍了2000年至2015年间主要从各种化学类别中分离出的具有体外和体内MAO抑制活性的植物源天然化合物实例。